Immunotech Laboratories, Inc.
IMMB · OTC
12/31/2016 | 12/31/2013 | 12/31/2009 | 12/31/2005 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $1 | $0 | $0 |
| Gross Profit | -$0 | -$1 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $1 | $0 |
| SG&A Expenses | $0 | $0 | $1 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $1 | $2 |
| Operating Income | -$0 | -$1 | -$1 | -$2 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$32 |
| Pre-Tax Income | -$0 | -$1 | -$1 | -$34 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$0 | -$1 | -$1 | -$34 |
| % Margin | – | – | – | – |
| EPS | -0.001 | -0.001 | 0 | -802 |
| % Growth | 35.7% | – | 100% | – |
| EPS Diluted | -0.001 | -0.001 | 0 | -802 |
| Weighted Avg Shares Out | 573 | 438 | 0 | 0 |
| Weighted Avg Shares Out Dil | 573 | 438 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | -$1 | -$1 | -$2 |
| % Margin | – | – | – | – |